Cancer Publications 2015

26 Jan 2023
26 Jan 2023
  1. Adeola, H.A. et al., 2015. Discovery of novel candidate urinary protein biomarkers for prostate cancer in a multiethnic cohort of South African patients via label-free mass spectrometry. PROTEOMICS - Clinical Applications, 9(5-6), pp.597–609.
  2. Adler, D. et al., 2015. High Risk Human Papillomavirus Persistence Among HIV-infected Young Women in South Africa. International Journal of Infectious Diseases, 33, pp.219–221.
  3. Aliwaini, S. et al., 2015. The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells. Cancer Letters, 357(1), pp.206–218.
  4. Asoogo, C. & Duma, S.E., 2015. Factors contributing to late breast cancer presentation for health care amongst women in Kumasi, Ghana. Curationis, 38(1).
  5. Beckenkamp, A. et al., 2015. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells M. E. L. Consolaro, ed. PLOS ONE, 10(7), p.e0134305.
  6. Chattopadhyay, K. et al., 2015. The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa. BMC Cancer, 15(1).
  7. Clifford, G.M. et al., 2015. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. International Journal of Cancer, 138(7), pp.1732–1740.
  8. Coulibaly, S.T. et al., 2015. Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase J.-L. E. Darlix, ed. PLOS ONE, 10(10), p.e0140741.
  9. Cremer, C. et al., 2015. Novel angiogenin mutants with increased cytotoxicity enhance the depletion of pro-inflammatory macrophages and leukemia cells ex vivo. Cancer Immunology, Immunotherapy, 64(12), pp.1575–1586.
  10. Dalwai, E. & Buccimazza, I., 2015. System delays in breast cancer. South African Journal of Surgery, 53(2), p.40.
  11. Dandara, C. et al., 2015. Patient and tumour characteristics as prognostic markers for oesophageal cancer: a retrospective analysis of a cohort of patients at Groote Schuur Hospital. European Journal of Cardio-Thoracic Surgery, 49(2), pp.629–634.
  12. De Vasconcellos, J.F. et al., 2015. SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1 D. Sarkar, ed. PLOS ONE, 10(8), p.e0134783.
  13. Denny, L. & Prendiville, W., 2015. Cancer of the cervix: Early detection and cost-effective solutions. International Journal of Gynecology & Obstetrics, 131, pp.S28–S32.
  14. Denny, L. & Wijk, L.V., 2015. Cervix. UICC Manual of Clinical Oncology, pp.449–466.
  15. Denny, L. et al., 2015. Cervical Cancer. Disease Control Priorities, Third Edition (Volume 3): Cancer, pp.69–84.
  16. Denny, L., 2015. Control of Cancer of the Cervix in Low- and Middle-Income Countries. Annals of Surgical Oncology, 22(3), pp.728–733.
  17. Dreyer, G. et al., 2015. School-based human papillomavirus vaccination: An opportunity to increase knowledge about cervical cancer and improve uptake of screening. South African Medical Journal, 105(11), p.912.
  18. Elhassan, M., Wu, H.-T. & Van Wijk, A., 2015. Epithelioid trophoblastic tumour: a report of two cases. Southern African Journal of Gynaecological Oncology, 7(1), pp.34–36.
  19. Govender, M. et al., 2015. Self-expanding metal stent placement for oesophageal cancer without fluoroscopy is safe and effective. South African Medical Journal, 105(10), p.858.
  20. Guler, R. et al., 2015. Targeting Batf2 for infectious diseases and cancer. Oncotarget, 6(29).
  21. Gupta, A., Mutebi, M. & Bardia, A., 2015. Gene-Expression-Based Predictors for Breast Cancer. Annals of Surgical Oncology, 22(11), pp.3418–3432.
  22. Kaschula, C.H. et al., 2015. The garlic compound ajoene targets protein folding in the endoplasmic reticulum of cancer cells. Molecular Carcinogenesis, 55(8), pp.1213–1228.
  23. Kew, MC., 2015. Obesity as a cause of hepatocellular carcinoma. Annals of Hepatology, pp. 299-303.
  24. Langa, B.C. et al., 2015. Copy Number Analysis of the DLX4 and ERBB2 Genes in South African Breast Cancer Patients. Cytogenetic and Genome Research, 146(3), pp.195–203.
  25. Laubscher, M., 2015. Primary bone tumours of the spine: Presentation surgical treatment and outcome. SA Orthopaedic Journal, pp. 22-28.
  26. Lecuona, K. et al., 2015. The treatment of carcinoma in situ and squamous cell carcinoma of the conjunctiva with fractionated strontium-90 radiation in a population with a high prevalence of HIV. British Journal of Ophthalmology, 99(9), pp.1158–1161.
  27. Matejcic, M. & Iqbal Parker, M., 2015. Gene–environment interactions in esophageal cancer. Critical Reviews in Clinical Laboratory Sciences, 52(5), pp.211–231.
  28. Matejcic, M. et al., 2015. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study. BMC Cancer, 15(1).
  29. Mbulawa, Z.Z.A., Coetzee, D. & Williamson, A.-L., 2015. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infectious Diseases, 15(1).
  30. Mladenov, R. et al., 2015. The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia. International Journal of Cancer, 137(11), pp.2729–2738.
  31. Moodley, J. et al., 2015. A bibliometric analysis of cancer research in South Africa: study protocol. BMJ Open, 5(2), pp.e006913–e006913.
  32. Movahedi, M. et al., 2015. Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. Journal of Clinical Oncology, 33(31), pp.3591–3597.
  33. Olleros, M.L. et al., 2015. Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF S. Ehrt, ed. Infection and Immunity, 83(9), pp.3612–3623
  34. Opie, L.H. & Lopaschuk, G.D., 2015. What is good for the circulation also lessens cancer risk. European Heart Journal, 36(19), pp.1157–1162.
  35. Paccez, J.D. et al., 2015. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma C.-H. Heldin, ed. Molecular Biology of the Cell, 26(5), pp.821–831.
  36. Passos, G. dos et al., 2015. Loupe magnification for head and neck free flap      reconstruction in a developing country. European Journal of Plastic Surgery, 38(5), pp.363–370.
  37. Peres, J., Mowla, S. & Prince, S., 2015. The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis. Oncotarget, 6(3).
  38. Quail, G. et al., 2015. Effect of cloth stoma covers on tracheal climate of laryngectomy patients. Head & Neck, 38(S1), pp.E480–E487.
  39. Quail, G. et al., 2015. Reply to letters to the editor concerning the article “The effect of cloth stoma covers on tracheal climate of laryngectomy patients.” Head & Neck, 38(2), pp.333–333.
  40. Rohner, E. et al., 2015. HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis. International Journal of Cancer, 138(1), pp.45–54.
  41. Schäfer, G., Blumenthal, M. & Katz, A., 2015. Interaction of Human Tumor Viruses with Host Cell Surface Receptors and Cell Entry. Viruses, 7(5), pp.2592–2617.
  42. Sengayi, M. et al., 2015. HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study. BMC Cancer, 15(1).
  43. Shamley, D. & Robb, K., 2015. An early warning surveillance programme for detecting upper limb deterioration after treatment for breast cancer: A novel technology supported system. BMC Cancer, 15(1).
  44. Shapiro, S. et al., 2015. Misrepresentation of the risk of ovarian cancer among women using menopausal hormones. Spurious findings in a meta-analysis. Maturitas, 81(2), pp.323–326.
  45. Shapiro, S., 2015. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical? Climacteric, 18(3), pp.333–335.
  46. Stefan, D.C. et al., 2015. Childhood cancer incidence in South Africa, 1987 - 2007. South African Medical Journal, 105(11), p.939.
  47. Tayib, S. et al., 2015. Human papillomavirus genotypes and clinical management of genital warts in women attending a colposcopy clinic in Cape Town, South Africa. South African Medical Journal, 105(8), p.679.
  48. Ten Haaf, A. et al., 2015. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies. Immunology Letters, 166(2), pp.65–78.
  49. Trimble, C.L. et al., 2015. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. The Lancet, 386(10008), pp.2078–2088.
  50. Viljoen, K.S. et al., 2015. Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer A. McDowell, ed. PLOS ONE, 10(3), p.e0119462.
  51. Wienand, K. & Shires, K., 2015. The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma Z. Ivanovic, ed. PLOS ONE, 10(3), p.e0120734.
  52. Yulyana, Y. et al., 2015. Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling. Molecular Therapy, 23(4), pp.746–756.
  53. Zhunussova, G. et al., 2015. Analysis of K-ras codon 12 and TP53 mutations in patients with advanced colorectal carcinoma. South African Medical Journal, 105(8), p.670.